Michael Walsh Email

Director Field Reimbursement . Kerecis

Current Roles

Employees:
675
Revenue:
$237.2M
About
Kerecis has developed the unique, patented Kerecisâ„¢ Omega3 fish-skin transplantation technology, where intact fish skin is used for tissue regeneration. The Kerecisâ„¢ Omega3 transplantation technology is used to reconstruct tissue damage such as burn and diabetic wounds as well as for oral wounds, hernia repair, breast reconstruction and for dura restoration. Other tissue-transplant products are based on tissues of human and porcine origin. The Kerecisâ„¢ Omega3 fish skin offers improved economics and clinical performance, as well as reduced disease transfer risk and no cultural constraints on usage. Kerecis' second technology platform is the patented mOmega3 polyunsaturated fatty acid technology, where fatty acids are extracted from fish skin and incorporated in patented dermatological skin treatment products.
Kerecis Address
2300 Clarendon Boulevard
Isafjordur, null
United States
Kerecis Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.